Granules India Ltd
NSE:GRANULES

Watchlist Manager
Granules India Ltd Logo
Granules India Ltd
NSE:GRANULES
Watchlist
Price: 596.85 INR 1.73%
Market Cap: 144.7B INR
Have any thoughts about
Granules India Ltd?
Write Note

Granules India Ltd
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Granules India Ltd
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Granules India Ltd
NSE:GRANULES
Total Assets
â‚ą55.2B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
17%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Assets
â‚ą467.3B
CAGR 3-Years
19%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Assets
â‚ą346.6B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
9%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Assets
â‚ą881.2B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
11%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Assets
â‚ą150.9B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Assets
â‚ą119.6B
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Granules India Ltd
Glance View

Market Cap
144.7B INR
Industry
Pharmaceuticals

In the bustling corridors of the pharmaceutical world, Granules India Ltd. has carved out a distinctive niche through its unwavering commitment to efficiencies and economies of scale. Founded in 1984, the company began its journey as an operator of a small Paracetamol facility and steadily evolved into a formidable player on the global stage. Granules India's business model is streamlined; it meticulously integrates its manufacturing processes, focusing primarily on Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosage Forms (FDFs). By leveraging vertically integrated operations, the company ensures a seamless transition from raw material to finished product, reducing costs while maintaining high standards of product quality, an achievement that distinguishes it in the competitive landscape. Granules India capitalizes on its robust manufacturing infrastructure, which operates round the clock to serve a diverse clientele spanning across regulated and semi-regulated markets. This emphasis on cost-effective production is coupled with strategic geographical placement of its facilities, allowing it to cater efficiently to domestic and international markets, including North America, Europe, and emerging economies. The company's revenue streams are largely driven by the sales of its extensive product portfolio, which includes key therapeutic areas like over-the-counter (OTC) brands and prescription medications. By maintaining a diversified product line and emphasizing high-volume, low-margin products, Granules India continually fortifies its market position while sustaining a healthy balance between growth and stability.

GRANULES Intrinsic Value
456.52 INR
Overvaluation 24%
Intrinsic Value
Price

See Also

What is Granules India Ltd's Total Assets?
Total Assets
55.2B INR

Based on the financial report for Sep 30, 2024, Granules India Ltd's Total Assets amounts to 55.2B INR.

What is Granules India Ltd's Total Assets growth rate?
Total Assets CAGR 10Y
17%

Over the last year, the Total Assets growth was 5%. The average annual Total Assets growth rates for Granules India Ltd have been 10% over the past three years , 12% over the past five years , and 17% over the past ten years .

Back to Top